Shares of ICU Medical Inc. (NASDAQ:ICUI) rose 2.1% during mid-day trading on Thursday . The stock traded as high as $125.56 and last traded at $124.71, with a volume of 59,705 shares. The stock had previously closed at $122.18.

Several research firms recently weighed in on ICUI. Zacks Investment Research raised ICU Medical from a “hold” rating to a “buy” rating and set a $140.00 price objective for the company in a research report on Friday, August 12th. Piper Jaffray Cos. reissued a “hold” rating and set a $115.00 price objective (up previously from $110.00) on shares of ICU Medical in a research report on Thursday, May 12th.

The firm has a 50-day moving average of $118.63 and a 200-day moving average of $105.38. The firm has a market capitalization of $2.03 billion and a price-to-earnings ratio of 37.39.

ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings data on Monday, August 8th. The company reported $1.15 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.10. The business had revenue of $96.70 million for the quarter, compared to analyst estimates of $89.66 million. The business’s quarterly revenue was up 15.4% compared to the same quarter last year. During the same period in the previous year, the business posted $0.97 EPS. Equities analysts forecast that ICU Medical Inc. will post $4.54 earnings per share for the current fiscal year.

In other ICU Medical news, VP Steven Riggs sold 20,000 shares of ICU Medical stock in a transaction dated Wednesday, June 29th. The stock was sold at an average price of $110.00, for a total value of $2,200,000.00. Following the sale, the vice president now owns 21,378 shares of the company’s stock, valued at approximately $2,351,580. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Joseph R. Saucedo sold 2,000 shares of ICU Medical stock in a transaction dated Friday, July 29th. The shares were sold at an average price of $115.47, for a total value of $230,940.00. Following the completion of the sale, the director now directly owns 4,348 shares in the company, valued at approximately $502,063.56. The disclosure for this sale can be found here.

An institutional investor recently bought a new position in ICU Medical stock. Airain ltd acquired a new stake in shares of ICU Medical Inc. (NASDAQ:ICUI) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 8,950 shares of the company’s stock, valued at approximately $1,009,000. Airain ltd owned 0.06% of ICU Medical as of its most recent filing with the SEC.

ICU Medical, Inc is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.